ClinicalTrials.gg
Drug

Rodatristat clinical trials

studies test it
6
open now
0
in phase 3
0
first study started
2015

How each study uses rodatristat is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Rodatristat Ethyl
3
rodatristat ethyl 600 mg BID
2

Development codes

KAR5585
1
RVT-1201
1

Studies by the year they started

6 studies that test it; most in 2021 (2)

Studies that test rodatristat, by start year
YearStudies
20151
20191
20212
20221
20231

By phase

A phase 1/2 study counts in both.

Phase 1
4
Phase 2
2

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 6 · Other 0

Altavant Sciences GmbH (5) · Karos Pharmaceuticals (1)

Studies

Open first, then newest update. How each study uses rodatristat is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 6

Codes

What other systems call rodatristat · ClinicalTrials.gg INT000729

  • MeSH (NLM) C000621040rodatristatOne source NLM
  • UNII (FDA) 91D8378G2VRODATRISTATConfirmed FDA, NLM
  • NCI Thesaurus C171780RodatristatOne source FDA

Also registered as rodatristat ethyl (UNII 507FY6OL37).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.